Knightscope Announces Strong Sales and Deployment Growth

Verizon Frontline to Host Robot Roadshow at Quantum Park MOUNTAIN VIEW, Calif., November 7, 2024 — [NASDAQ:KSCP] (“Knightscope” or the “Company”), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces 14 new sales, 10 client renewals and 4 new security robot deployments. Knightscope attributes…

Cavendish Clinics Upgrades Microneedling Device Offering with Award-Winning SkinPen® Precision

LONDON, Nov. 6, 2024 — Crown Aesthetics, a Crown Laboratories company and leading innovator in the dermatologic and aesthetics industry, is pleased to announce that Cavendish Clinics, one of the United Kingdom’s (“UK”) premier aesthetic clinic groups, has upgraded their microneedling devices to the award-winning . This upgrade significantly enhances…

TERAGO Wins Major Contract with Canadian Retailer for Nationwide Connectivity

This multi-million-dollar agreement will transform connectivity across the retailer’s nationwide operations, enhancing performance and customer experience. TORONTO, Nov. 5, 2024 – TERAGO Inc. (“TERAGO” or the “Company”) (TSX: TGO) (), a leading provider of Managed Fixed Wireless Internet and SDWAN solutions, announced today that a major Canadian retailer has chosen…

DMEGC Solar Achieves First Carbon-Neutral Factory, Three Plants Powered by 100% Renewable Energy

DONGYANG, China, Nov. 6, 2024 — DMEGC Solar’s Lianyungang Factory has earned the ISO 14068 Organizational Carbon Neutrality Achievement Verification Statement, marking the first such certification awarded by TÜV SÜD in the solar photovoltaic industry. Simultaneously, DMEGC Solar’s three factories in Sihong, Lianyungang, and Yibin have received both the Organizational…

Leads Biolabs’ Anti-Cancer Antibody LBL-034 Receives Orphan Drug Designation from the US FDA for Multiple Myeloma Treatment

NANJING, China, Nov. 6, 2024 — On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which is independently developed by Leads Biolabs with global intellectual property rights for treatment of multiple…

AMPCO METAL Expands Capabilities and Customer Offerings through Schmelzmetall Group Acquisition

MARLY, Switzerland, Nov. 6, 2024 —  AMPCO METAL, a global leader in copper-based alloys, is pleased to announce its acquisition of Switzerland-based Schmelzmetall Group, a renowned producer of high-performance copper alloys. This strategic acquisition strengthens AMPCO METAL’s position in the industry and expands its offerings to better serve customers across…